Portage Biotech Inc reports results for the quarter ended in June - Earnings Summary

Alpha Compute

01/09/2023 07:51

* Portage Biotech Inc  PRTG.OQ  reported a quarterly
adjusted loss
of 33 cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 24
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Portage Biotech Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Portage Biotech Inc shares had fallen by 26.8% this
quarter and
lost 51.6% so far this year.
    * The company reported a quarterly loss of $5.93 million.
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
September 1 at 06:51 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.24          -0.33          Missed
 Mar. 31 2023      -5.43          -5.86          Missed
 Dec. 31 2022      -0.23          -0.44          Missed
 Sep. 30 2022      -0.29          -0.06          Beat